Innovator IBD ETF Leaders ETF
LDRS
LDRS was delisted on the 13th of August, 2021.
23 hedge funds and large institutions have $9.53M invested in Innovator IBD ETF Leaders ETF in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
15% more funds holding
Funds holding: 20 → 23 (+3)
3% more capital invested
Capital invested by funds: $9.23M → $9.53M (+$299K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$680K |
| 2 |
VF
Virtu Financial
New York
|
+$348K |
| 3 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$245K |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$230K |
| 5 |
Koshinski Asset Management
Decatur,
Illinois
|
+$54.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$545K |
| 2 |
LPL Financial
San Diego,
California
|
-$467K |
| 3 |
NFG
Next Financial Group
Houston,
Texas
|
-$252K |
| 4 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
-$145K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$106K |
LDRS Hedge Fund Activity: Q2 2018 in Review
23 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q2 2018, worth a combined $9.53M — up 3.2% from $9.23M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new LDRS positions and 1 closed out — a net gain of 3 holders — while 7 added to existing stakes and 6 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $680K. The largest seller was Royal Bank of Canada, cutting an estimated $545K.
- 23 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q2 2018, up from 20 in Q1 2018.
- Funds reported $9.53M of Innovator IBD ETF Leaders ETF stock for Q2 2018, up 3.2% quarter-over-quarter.
- 4 funds opened new Innovator IBD ETF Leaders ETF positions in Q2 2018 and 1 closed out, a net change of +3 holders.
- The largest Innovator IBD ETF Leaders ETF buyer in Q2 2018 was Citadel Advisors, an estimated $680K added.
- The largest Innovator IBD ETF Leaders ETF seller in Q2 2018 was Royal Bank of Canada, an estimated $545K sold.
Based on aggregated 13F filings for Q2 2018.